Viewing Study NCT02398058


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2026-01-04 @ 8:38 AM
Study NCT ID: NCT02398058
Status: COMPLETED
Last Update Posted: 2021-04-14
First Post: 2015-01-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)
Sponsor: Italian Sarcoma Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module